Core Insights - SS Innovations International, Inc. is set to ring the opening bell at Nasdaq on June 3, 2025, marking a significant milestone following its uplisting in April 2025 [1][2] - The company has successfully completed over 4,000 robotic surgeries using its SSi Mantra system, achieving this without any complications, injuries, or mortalities [2] - SS Innovations aims to expand its market presence globally, including in the European Union and the United States, to make robotic surgery more accessible and affordable [2][3] Company Overview - SS Innovations develops innovative surgical robotic technologies, focusing on making robotic surgery affordable and accessible to a larger global population [3] - The company's flagship product, the SSi Mantra, is a modular surgical robotic system designed for various surgical procedures, including cardiac surgery [4] - The SSi Mantra features advanced technology such as modular robotic arms, a 3D 4K monitor, and a comprehensive suite of surgical instruments [4] Market Position and Future Plans - The company is experiencing growing acceptance of the SSi Mantra among physicians in India and six other countries, indicating a positive market reception [2] - SS Innovations is actively pursuing new markets to enhance the global deployment of its surgical robotic solutions [2][3]